🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 31% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

3 Capsule(s) Serving Size
30 Servings
Other Combinations Product Type
31% Evidence Coverage

Supplement Facts — Evidence Check

300 mg
📊 Market median: 400.0mg (380 products) 📚 34 studies (Tier A: 1, B: 10)
This product: 300mg
300 mg
📊 Market median: 260.0mg (249 products) 📚 156 studies (Tier A: 4, B: 61)
This product: 300mg
📊 Market median: 470.0mg (230 products) 📚 9 studies (Tier A: 3, B: 3)
This product: 200mg
📊 Market median: 175.0mg (497 products) 📚 11 studies (Tier A: 0, B: 1)
This product: 200mg
Andrographis
200 mg
Arabinogalactan
100 mg
Goldenseal
100 mg
Lauric Acid
100 mg
Cordyceps Mushroom
50 mg
Shiitake Mushroom
50 mg
Maitake Mushroom
50 mg
📊 Market median: 340.0mg (243 products) 📚 3 studies — no high-quality reviews
This product: 50mg
Beta 1,3 Glucan
9 mg

Other Ingredients

Microcrystalline Cellulose Vegetable Stearate

Label Claims — Verification

All Other
All Other (99% of products) Structure/Function (74% of products) Nutrient (3% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free

Product Information

📋 Directions for Use

Recommended Use: As a dietary supplement, take three capsules per day with meals, or as directed by your health care practitioner.

⚠️ Warnings & Precautions

Warning: Not recommended for pregnant or lactating women.

KEEP OUT OF REACH OF CHILDREN.

🧪 Formulation Notes

Does not contain gluten.

Additional Information

Notice: Color, size or shape may appear different between lots.

IMP090

For Professional Use Only

Guaranteed GMP COMPLIANT Products

Manufactured in an NSF GMP Registered Facility

STORE IN A COOL, DRY PLACE.

Product Details

UPC / SKU 8 79452 00068 1
DSLD Entry Date 2013-06-25
Product Type Other Combinations
Form Capsule
DSLD ID 22931
Data Updated 2026-04-11

Research Evidence

38 Research Sources
52 Avg Quality Score
15 Meta Analysis
12 Systematic Review
6 Rct
2 Clinical Trial
1 Regulatory Source
1 Openfda Safety
A Echinacea for preventing and treating the common cold
Meta Analysis The Cochrane database of systematic reviews 2014
B Efficacy and safety of Echinacea purpurea in treating upper respiratory infections and complications of otitis media in children: Systematic review and meta-analysis
Meta Analysis Clinical nutrition ESPEN 2025
B Echinacea for preventing and treating the common cold
Systematic Review The Cochrane database of systematic reviews 2000
B Echinacea Supplementation Does Not Impact Aerobic Capacity and Erythropoiesis in Athletes: A Meta-Analysis
Meta Analysis Nutrients 2024
B Echinacea for preventing and treating the common cold
Meta Analysis The Cochrane database of systematic reviews 2006
B Therapeutic Potential of a Natural Blend of Aronia melancarpa, Lonicera caerulea, and Echinacea purpurea Extracts in Treating Upper Respiratory Tract Infections: Preliminary Clinical and In Vitro Immunomodulatory Insights
Rct International journal of molecular sciences 2024
B Herbal Medicine in Children With Respiratory Tract Infection: Systematic Review and Meta-Analysis
Meta Analysis Academic pediatrics 2018
B Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis
Meta Analysis The Lancet. Infectious diseases 2007
B Herbal Medicine for Cough: a Systematic Review and Meta-Analysis
Meta Analysis Forschende Komplementarmedizin (2006) 2015
B Echinacea for the prevention and treatment of upper respiratory tract infections: A systematic review and meta-analysis
Meta Analysis Complementary therapies in medicine 2019
View all evidence for Echinacea →

Compare Similar Products

View all Echinacea products →